Fig. 2From: Can the apparent transverse relaxation rate (R2*) evaluate the efficacy of concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma? a preliminary experienceAn elderly man with nasopharyngeal carcinoma (AJCC stage III). (a) Axial enhanced fat suppression T1WI before CCRT with lesions located on the left side. (b) Axial enhanced fat suppression T1WI at 3 months after the end of CCRT indicates a partial response (PR) according to RECIST 1.1; the patient was included in RG. (c) R2* value in the ROI was 45.90 Hz on the R2* color-coded map before CCRT. (d) R2* value in the ROI was 66.40 Hz at 3 months after the end of CCRT. CCRT, concurrent chemoradiotherapy; RECIST, response evaluation criteria for solid tumors; RG, responding group; ROI, region of interest; AJCC, American Joint Committee on Cancer; T1WI, T1-weighted imageBack to article page